ViewRay Inc. (Nasdaq: VRAY) of Oakwood Village has won regulatory approval for its MRIdian Linac technology in Japan, which the company's CEO characterized as "an important milestone in the system's ...
A section of the new MR-linac imaging system is hoisted into a radiation therapy vault at the Froedtert and MCW Clinical Cancer Center. Subscribe to BizTimes Daily – Local news about the people, ...
CLEVELAND, March 15, 2018 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today that the company received Shonin approval from the Japanese Ministry of Health, Labor and Welfare (MHLW) to ...
CLEVELAND, Feb. 4, 2021 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today that Edogawa Hospital in Tokyo is the first hospital in Japan to treat patients with the MRIdian Linac System.
Viewray Inc. received FDA clearance for the Mridian Linac system, a device that allows clinicians to visualize in real time the movement of tumors and organs during radiation treatment. The Oakwood, ...
Mercy Health – Lorain continues to grow its radiation oncology services, with the addition of a new, upgraded linear accelerator, also known as a LINAC. Lake Shore Electric is featured program at ...
The commissioning and quality assurance of an MR-Linac presents medical physicists with many technical and dosimetric challenges. Having a 3D water phantom system is beneficial for saving time and for ...
Chris Raanes is the man responsible for guiding the growth and development of ViewRay Inc., the Oakwood Village-based maker of an MRI-guided radiation therapy system that in the fall raised about $50 ...
The THALES 3D MR SCANNER from LAP is helping medical physicists to fast-track QA test routines on their MR-guided radiotherapy systems, while a new iteration of the phantom delivers similar workflow ...
Subscribe to BizTimes Daily – Local news about the people, companies and issues that impact business in Milwaukee and Southeast Wisconsin. An installation crew recently used a crane to hoist a massive ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results